Inspira and Bites Form Strategic Alliance to Embed AI as a Core Standard Across Inspira’s Global Ecosystem
PartnersCustomers
Inspira Appoints Former Johnson & Johnson Executive as VP of Global Sales and New Board Member from a Leading International Investment Firm
Management Changes
Inspira Appoints Former Johnson & Johnson Senior Business Manager as VP of Global Sales and New Board Member from a Leading International Investment Firm
Management Changes
Inspira Technologies Reports First Half 2025 Financial Results and Issues Business Update
Product StageCustomersFDA approved/pending approvalPartners
All You Need to Know About Inspira Technologies OXY (IINN) Rating Upgrade to Buy
Inspira to Unveil HYLA™ Real-Time Blood Sensor at U.S. ELSO; 97.35% Accuracy Confirmed
Product StagePartners
Inspira Announces 97.3% Accuracy Results for HYLA™ Blood Sensor, Advancing Toward FDA Submission for Clearance
Product StageFDA approved/pending approval
When Will Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) Become Profitable?
Top U.S. Honor Roll Hospital Expands Use of INSPIRA™ ART100 System to Lung Transplant Procedures
CustomersProduct Stage
Inspira Receives U.S. Patent Approval for the ART500 Core Technology, Key Patent Positions the Company to Dominate $20 Billion Estimated Market
Product StageFDA approved/pending approval
Inspira Secures $27 Million Government Binding Purchase Order for ART100 Systems with Full Payment in 2025
CustomersPartners
Inspira Clarifies Routine Nature of Registration Statement on Form F-3 Filing Performed Every Three Years
Product StageFDA approved/pending approval
Inspira Activates U.S. Based Consulting Firm to Execute Transformational Initiatives
PartnersCustomersProduct Stage
Inspira Regains Compliance with Nasdaq Minimum Bid Price Requirement
Product StageCustomersPartnersInvestment
Inspira Achieves All Key Objectives in Previously Announced Government Talks, Forging a Pathway to National Adoption and Global Scale-Up of the ART100
PartnersCustomers
Inspira in High-Level Government Talks to Advance National Integration of the ART100 and Establish a Global Distribution Framework
CustomersPartners
Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase
CustomersProduct Stage
Inspira Technologies says ART100 in use at Tier-1 U.S. hospitals
Product StageCustomers
Inspira’s ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions
Product StageCustomersFDA approved/pending approval
Inspira Technologies scales up ART100 production capabilities
Product StageCustomersManagement Changes
+ 150 more articles
